RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS

Gangat, 2016, Myelodysplastic syndromes: contemporary review and how we treat, Am J Hematol, 91, 76, 10.1002/ajh.24253 Haferlach, 2014, Landscape of genetic lesions in 944 patients with myelodysplastic syndromes, Leukemia, 28, 241, 10.1038/leu.2013.336 Papaemmanuil, 2013, Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, 122, 3616, 10.1182/blood-2013-08-518886 Chen, 2007, RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome, Br J Haematol, 139, 405, 10.1111/j.1365-2141.2007.06811.x Tsai, 2015, Biological activities of RUNX1 mutants predict secondary acute leukemia transformation from chronic myelomonocytic leukemia and myelodysplastic syndromes, Clin Cancer Res, 21, 3541, 10.1158/1078-0432.CCR-14-2203 Ito, 2015, The RUNX family: developmental regulators in cancer, Nat Rev Cancer, 15, 81, 10.1038/nrc3877 Sood, 2017, Role of RUNX1 in hematological malignancies, Blood, 129, 2070, 10.1182/blood-2016-10-687830 Chen, 2021, Splicing factor mutations in hematologic malignancies, Blood, 138, 599, 10.1182/blood.2019004260 Bejar, 2011, Clinical effect of point mutations in myelodysplastic syndromes, N Engl J Med, 364, 2496, 10.1056/NEJMoa1013343 Yoshida, 2011, Frequent pathway mutations of splicing machinery in myelodysplasia, Nature, 478, 64, 10.1038/nature10496 Papaemmanuil, 2011, Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts, N Engl J Med, 365, 1384, 10.1056/NEJMoa1103283 Walter, 2012, Clonal architecture of secondary acute myeloid leukemia, N Engl J Med, 366, 1090, 10.1056/NEJMoa1106968 Sperling, 2017, The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia, Nat Rev Cancer, 17, 5, 10.1038/nrc.2016.112 Pellagatti, 2016, Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression, Leukemia, 30, 247, 10.1038/leu.2015.129 Thol, 2012, Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes, Blood, 119, 3578, 10.1182/blood-2011-12-399337 Wu, 2012, The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution, Blood, 120, 3106, 10.1182/blood-2012-02-412296 Kim, 2015, SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition, Cancer Cell, 27, 617, 10.1016/j.ccell.2015.04.006 Komeno, 2015, SRSF2 is essential for hematopoiesis, and its myelodysplastic syndrome-related mutations dysregulate alternative pre-mRNA splicing, Mol Cell Biol, 35, 3071, 10.1128/MCB.00202-15 Smeets, 2018, Srsf2(P95H) initiates myeloid bias and myelodysplastic/myeloproliferative syndrome from hemopoietic stem cells, Blood, 132, 608, 10.1182/blood-2018-04-845602 Kon, 2018, Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice, Blood, 131, 621, 10.1182/blood-2017-01-762393 Zhang, 2015, Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities, Proc Natl Acad Sci U S A, 112, E4726, 10.1073/pnas.1514105112 Damm, 2012, Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes, Blood, 119, 3211, 10.1182/blood-2011-12-400994 Gaidzik, 2016, RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features, Leukemia, 30, 2160, 10.1038/leu.2016.126 Ochi, 2020, Combined cohesin-RUNX1 deficiency synergistically perturbs chromatin looping and causes myelodysplastic syndromes, Cancer Discov, 10, 836, 10.1158/2159-8290.CD-19-0982 Growney, 2005, Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype, Blood, 106, 494, 10.1182/blood-2004-08-3280 Shastri, 2017, Stem and progenitor cell alterations in myelodysplastic syndromes, Blood, 129, 1586, 10.1182/blood-2016-10-696062 Ichikawa, 2004, AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis, Nat Med, 10, 299, 10.1038/nm997 Pang, 2013, Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes, Proc Natl Acad Sci U S A, 110, 3011, 10.1073/pnas.1222861110 Pollyea, 2019, Myelodysplastic syndrome-associated spliceosome gene mutations enhance innate immune signaling, Haematologica, 104, e388, 10.3324/haematol.2018.214155 van Wijnen, 2004, Nomenclature for Runt-related (RUNX) proteins, Oncogene, 23, 4209, 10.1038/sj.onc.1207758 Mo, 2013, Unique role of SRSF2 in transcription activation and diverse functions of the SR and hnRNP proteins in gene expression regulation, Transcription, 4, 251, 10.4161/trns.26932 Ji, 2013, SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase, Cell, 153, 855, 10.1016/j.cell.2013.04.028 Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS, 16, 284, 10.1089/omi.2011.0118 Wang, 2000, Requirement for ERK activation in cisplatin-induced apoptosis, J Biol Chem, 275, 39435, 10.1074/jbc.M004583200 Cagnol, 2010, ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence, FEBS J, 277, 2, 10.1111/j.1742-4658.2009.07366.x Zhou, 2013, Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?, Exp Hematol, 41, 665, 10.1016/j.exphem.2013.04.008 Popp, 2017, Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias, Leuk Res, 57, 112, 10.1016/j.leukres.2017.03.011 Ogawa, 2019, Genetics of MDS, Blood, 133, 1049, 10.1182/blood-2018-10-844621 Singh, 2020, SF3B1 mutations induce R-loop accumulation and DNA damage in MDS and leukemia cells with therapeutic implications, Leukemia, 34, 2525, 10.1038/s41375-020-0753-9 Nguyen, 2018, Spliceosome mutations induce R loop-associated sensitivity to ATR inhibition in myelodysplastic syndromes, Cancer Res, 78, 5363, 10.1158/0008-5472.CAN-17-3970 Cantor, 2001, BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function, Cell, 105, 149, 10.1016/S0092-8674(01)00304-X Cantor, 2004, The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations, Proc Natl Acad Sci U S A, 101, 2357, 10.1073/pnas.0308717101 Seal, 2006, Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles, Nat Genet, 38, 1239, 10.1038/ng1902 Levitus, 2005, The DNA helicase BRIP1 is defective in Fanconi anemia complementation group, J Nat Genet, 37, 934 Levran, 2005, The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia, Nat Genet, 37, 931, 10.1038/ng1624 Wu, 2010, Fanconi anemia group J mutation abolishes its DNA repair function by uncoupling DNA translocation from helicase activity or disruption of protein-DNA complexes, Blood, 116, 3780, 10.1182/blood-2009-11-256016 Guo, 2014, Insight into the roles of helicase motif Ia by characterizing Fanconi anemia group J protein (FANCJ) patient mutations, J Biol Chem, 289, 10551, 10.1074/jbc.M113.538892 Huang, 2009, SOSS complexes participate in the maintenance of genomic stability, Mol Cell, 35, 384, 10.1016/j.molcel.2009.06.011 Li, 2009, HSSB1 and hSSB2 form similar multiprotein complexes that participate in DNA damage response, J Biol Chem, 284, 23525, 10.1074/jbc.C109.039586 Trujillo, 2012, On the role of FAN1 in Fanconi anemia, Blood, 120, 86, 10.1182/blood-2012-04-420604 Smogorzewska, 2010, A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair, Mol Cell, 39, 36, 10.1016/j.molcel.2010.06.023 Yoshikiyo, 2010, KIAA1018/FAN1 nuclease protects cells against genomic instability induced by interstrand cross-linking agents, Proc Natl Acad Sci U S A, 107, 21553, 10.1073/pnas.1011081107 Edwards, 1997, Human CPR (cell cycle progression restoration) genes impart a Far- phenotype on yeast cells, Genetics, 147, 1063, 10.1093/genetics/147.3.1063 Li, 2006, A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity, Genes Dev, 20, 2566, 10.1101/gad.1455006 van Wijk, 2005, The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis, Blood, 106, 4034, 10.1182/blood-2005-04-1622 Garcia, 2009, Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis, PLoS Genet, 5, e1000615, 10.1371/journal.pgen.1000615 Mukherjee, 2002, The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements, EMBO J, 21, 165, 10.1093/emboj/21.1.165 West, 2006, Adenylation and exosome-mediated degradation of cotranscriptionally cleaved pre-messenger RNA in human cells, Mol Cell, 21, 437, 10.1016/j.molcel.2005.12.008 van Dijk, 2007, Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathways, RNA, 13, 1027, 10.1261/rna.575107 Sternberg, 2005, Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome, Blood, 106, 2982, 10.1182/blood-2005-04-1543 Yoshimi, 2019, Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis, Nature, 574, 273, 10.1038/s41586-019-1618-0 Fei, 2018, Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene U2af1, Proc Natl Acad Sci U S A, 115, E10437, 10.1073/pnas.1812669115 Grinev, 2021, RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia, Nat Commun, 12, 520, 10.1038/s41467-020-20848-z Barton, 2009, Characterization of RNA aptamers that disrupt the RUNX1-CBFbeta/DNA complex, Nucleic Acids Res, 37, 6818, 10.1093/nar/gkp728 Fukunaga, 2013, The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a DNA element, RNA, 19, 927, 10.1261/rna.037879.112 Kornblihtt, 2004, Multiple links between transcription and splicing, RNA, 10, 1489, 10.1261/rna.7100104 Pandya-Jones, 2009, Co-transcriptional splicing of constitutive and alternative exons, RNA, 15, 1896, 10.1261/rna.1714509 Xu, 2022, Genome-wide screening identifies cell cycle control as a synthetic lethal pathway with SRSF2P95H mutation, Blood Adv, 6, 2092, 10.1182/bloodadvances.2021004571 Chen, 2018, The augmented R-loop is a unifying mechanism for myelodysplastic syndromes induced by high-risk splicing factor mutations, Mol Cell, 69, 412, 10.1016/j.molcel.2017.12.029 Bellissimo, 2017, RUNX1 mutations in inherited and sporadic leukemia, Front Cell Dev Biol, 5, 111, 10.3389/fcell.2017.00111 Samarakkody, 2020, Role of RUNX family transcription factors in DNA damage response, Mol Cells, 43, 99